Skip to main content

Table 2 Table 1

From: Randomized phase II – study evaluating EGFR targeting therapy with Cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer – PARC: study protocol [ISRCTN56652283]

Investigation Pretreatment Chemoradiation / Chemotherapy weekly Each Course of Infusional Gemcitabine/ Cetuximab follow-up
Clinical examination X X X X
Laboratory tests Xa X X X
Tumor markers Xb X X X
CT Abdomen X    Xc
CXR, PA, LAT X   X X
Renal function Xd    
Pregnancy Test f X    
SAE X X X  
QOL Survey Xe X X X
  1. a. Includes Electrolytes, BUN, Creatinine, SGOT, Alk Phos, Total Bilirubin, Albumin, Glucose, Calcium, auto-antibodies
  2. b. Includes CEA and CA 19-9
  3. c. A CT scan will be performed 4 weeks after chemoradiation and than every 3 months.
  4. d. Includes CT with i.v. contrast
  5. e. QLQ-C30, QLQ-Pan 26
  6. f. If indicated